EHA 2019 | Whole transcriptome RNA sequencing in AML

Name: Whole transcriptome RNA sequencing in AML
Uploaded: 2019-06-14T00:00:00.000Z
Duration: 1 min 17 s
Description: Here, Peter Valk, PhD, from the Erasmus University Medical Center, Rotterdam, Netherlands, discusses whole transcriptome RNA sequencing in acute myeloid leukemia (AML), at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands. This study investigated prognostic mutations, markers and expression levels such as EVR1.

Peter Valk • 14 Jun 2019

EHA 2019

Acute Myeloid Leukemia Leukemia

Here, Peter Valk, PhD, from the Erasmus University Medical Center, Rotterdam, Netherlands, discusses whole transcriptome RNA sequencing in acute myeloid leukemia (AML), at the 24th Congress of the European Hematology Association (EHA) 2019, held in Amsterdam, Netherlands. This study investigated prognostic mutations, markers and expression levels such as EVR1.